CELLULAR LIFT REGENERATION (CLR)
Live / Registered — Registered (as of 25 Aug 2026)
What this means for you
Registered since 25 Aug 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 25 Aug 2032: the §71 affidavit of use).
Record
- Serial number
- 79429030
- Registration number
- 8407650
- Mark type
- Slogan / phrase
- Filed
- 05 Jun 2025
- Published for opposition
- 07 Jul 2026
- Registered
- 25 Aug 2026
- Next maintenance filing
- §71 affidavit of use, due by 25 Aug 2032 (grace period to 25 Feb 2033)
- Attorney of record
- W. Tyler Hall
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and veterinary preparations, in particular for the prevention and treatment of cartilage and bone diseases; chemicals for medical purposes, in particular for the prevention and treatment of cartilage and bone diseases; biological preparations for use in cell cultures for medical purposes; medicines for use in human and veterinary medicine for the treatment of bone diseases, osteoarthritis, cartilage defects, arthrosis and traumatic cartilage injuries; drug delivery agents in the form of tablets, capsules, pastilles, and granules that facilitate the delivery of pharmaceutical preparations; ointments for pharmaceutical purposes for the treatment of bone diseases, osteoarthritis, cartilage defects, arthrosis and traumatic cartilage injuries; injection solutions for pharmaceutical purposes for the treatment of bone diseases, osteoarthritis, cartilage defects, arthrosis and traumatic cartilage injuries; dietetic foods and beverages adapted for use in human and veterinary medicine; therapeutic food for dietetic medical purposes; medicinal drinks; dietary supplements, in particular for medical purposes; vitamin and multi-vitamin preparations, in particular for medical purposes; mineral supplements and mineral preparations, in particular for medical purposes; biological and chemical preparations for medical diagnostic purposes for use in laboratories, pharmacies and doctors' surgeries; chemical test preparations for medical diagnostic purposes, in particular reagents, standard solutions, biological indicators and cell culture media; pre-filled syringes sold filled with cell growth factors, analgesics, hyaluronic acid and its derivates, vitamins and minerals
- Class 010 — Medical apparatus: Surgical apparatus and instruments; medical and dental apparatus and instruments, namely, arthroscopic trocar, arthroscopic working sleeves, arthroscopic drills and arthroscopic plungers; vials sold empty for the purpose of medical infusions; medical analytical apparatus, namely, X-ray apparatus, computed tomography apparatus, magnetic resonance imaging apparatus and arthroscopes; implants consisting of artificial materials for use in human and veterinary medicine, in particular for the prevention and treatment of cartilage and bone diseases
- Class 016 — Paper goods and printed matter: Printed matter, namely brochures for patients and magazines with advertising, including for pharmacies and doctors, all the aforesaid relating to the prevention and treatment of cartilage and bone diseases
Owner
- Dr. Christoph Karl, Tägerwilen, DE
- Dr. Christoph Karl, Tägerwilen, DE
- Dr. Christoph Karl, Tägerwilen, DE
Prosecution history
- 25 Aug 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Aug 2026 — REGISTERED-PRINCIPAL REGISTER
- 07 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jul 2026 — PUBLISHED FOR OPPOSITION
- 01 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Jun 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 11 Jun 2026 — EXAMINER'S AMENDMENT ENTERED
- 11 Jun 2026 — EXAMINERS AMENDMENT E-MAILED
- 11 Jun 2026 — EXAMINERS AMENDMENT -WRITTEN
- 10 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Dec 2025 — REFUSAL PROCESSED BY IB
- 10 Dec 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB